http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109608492-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3882 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 |
| filingDate | 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109608492-B |
| titleOfInvention | Diphosphonic acid compound for osteoporosis and preparation method thereof |
| abstract | The invention discloses a diphosphonic acid compound with a novel structure, which comprises an ibuprofen structural unit and a phenylalanine structural unit. Pharmacological tests show that the diphosphonic acid compound can be used for treating osteoporosis, the activity of inhibiting osteoclasts is basically equivalent to that of the marketed diphosphonic acid drugs such as alendronate sodium and zoledronic acid, and meanwhile, the diphosphonic acid compound also has a good effect of promoting osteoblast proliferation. |
| priorityDate | 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.